Moderna shares jump as intismeran autogene nears next test
Moderna said it will present three abstracts on intismeran autogene, its personalized mRNA cancer vaccine, ahead of its next major test.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.